Diplomat Specialty Pharmacy® and Diplomat Specialty Infusion Group® are joining the Optum® family.

To learn more about what this means for you, visit our FAQ pages:

Specialty Pharmacy FAQ  •  Infusion Pharmacy FAQ

Husband and wife hug

Simplifying Therapy for Alpha-1 Antitrypsin Deficiency

Diplomat Specialty Infusion Group combines clinical expertise with personalized care.

AATD is an inherited condition that causes AAT proteins, which protect the lungs and other organs, to get trapped in the liver. This increases risks of cirrhosis and other liver diseases.


People with AATD are most susceptible to life-threatening lung diseases. They can develop emphysema early in life (usually between ages 40 and 50). Risk factors include exposure to tobacco smoke, toxic substances, dust, and fumes.


Rarely, people with AATD can develop a painful skin disease called necrotizing panniculitis.


People with AATD inherit the condition from their parents. Each parent must pass on a faulty AAT gene for their child to have AATD. However, even people with two faulty AAT genes might not have symptoms or even know they have AATD. People with one faulty gene will not have AATD, but could pass the gene to their children.


The first symptoms of AATD usually occur between ages 20 and 40, although liver complications are often diagnosed in infancy and early childhood.


For drug information, click here.


Prescriber? Find enrollment forms here.

How can Diplomat help me?

We’ll answer your questions about Diplomat Specialty Infusion Group.


Illustration of pills coming out of a faucet

Upcoming Treatments

We keep you informed about new specialty medications.

Diplomat actively monitors specialty medications in the government's review and approval process. You can search our database to see if there will be new treatment options for your condition you can discuss with your doctor.

Search Our Database.

Woman uses calculator

Financial Assistance

We’ll look for ways to help you afford therapy.

There are many ways to get help paying for specialty medications. We'll seek third-party programs and support the application process from start to finish.

Learn More

Meet our patients.

jodie image

When therapy was approved to treat Jodie’s hypokalemic periodic paralysis, Diplomat was there to help.

Read more

After being diagnosed with multiple sclerosis, Bethany retired. Diplomat helped her adjust to a new normal.

Read more

After living with Crohn's disease for 18 years, Dave needed nutritional support. Diplomat helped him thrive.

Read more

Jacque thought she’d live with hepatitis C forever. But with Diplomat’s help and expertise, she found a cure.

Read more

Still have questions?

Get the answers you need.